Summary

A randomized, observer-blind, placebo-controlled, multi-center, multi-national, Phase III trial evaluating the efficacy, immunogenicity, and safety of a clostridium difficile (C difficile) toxoid vaccine in subjects at risk for C difficile infection (CDI).

Register to download

Overcoming Difficult Recruitment Challenges to Meet Vaccine Study Enrollment Goals

You may also be interested in: